Table 1.
Demographic and clinical data of the patients at the time of the MR session.
| N | 1 | 2 | 3 | 4 | 5 | 6 | Mean | (SD) |
|---|---|---|---|---|---|---|---|---|
| Age (yrs) | 46 | 58 | 52 | 46 | 48 | 57 | 51.2 | (5.4) |
| Sex | F | M | F | M | M | M | – | – |
| Age at onset (yrs) | 60 | 55 | 48 | 41 | 54 | 51 | 51.5 | (6.5) |
| Side of onset | R | L | R | R | L | R | – | – |
| Disease duration (yrs) | 6 | 3 | 4 | 5 | 4 | 6 | 4.7 | (1.2) |
| HY stage | 2 | 2 | 2 | 2 | 2 | 2 | 2 | – |
| UPDRS III - OFF | 19 | 17 | 18 | 17 | 19 | 15 | 17.5 | (1.5) |
| UPDRS III - ON | 9 | 6 | 10 | 8 | 10 | 10 | 8.8 | (1.6) |
| UPDRS III reduction (%) | 53 | 65 | 44 | 53 | 48 | 33 | 49.3∗ | (10.7) |
Yrs, years; HY, Hoehn and Yahr staging of severity of Parkinson disease; UPDRS, unified Parkinson’s Disease Rating Scale reported as score; ∗significant (p < 0.05).